Dean L Schorno insider trades: Rigel Pharmaceuticals (RIGL) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Dean reports to the SEC
Open-market buys and sales
28 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Feb 5, 2025 | RIGL | ↓ Sell | 3,770 | $21.38 | $81K | Direct | Feb 6, 2025 (1d) |
| Feb 5, 2024 | RIGL | ↓ Sell | 12,628 | $1.14 | $14K | Direct | Feb 6, 2024 (1d) |
| Feb 2, 2023 | RIGL | ↓ Sell | 5,389 | $1.66 | $9K | Direct | Feb 6, 2023 (4d) |
| May 22, 2019 | RIGL | ↑ Buy | 50,000 | $2.13 | $107K | Direct | May 23, 2019 (1d) |
| Jun 10, 2014 | GHDX | ↓ Sell | 4,000 | $27.62 | $110K | Direct | Jun 13, 2014 (3d) |
| May 9, 2014 | GHDX | ↓ Sell | 4,000 | $25.09 | $100K | Direct | May 13, 2014 (4d) |
| Dec 9, 2013 | GHDX | ↓ Sell | 3,000 | $33.25 | $100K | Direct | Dec 10, 2013 (1d) |
| Nov 8, 2013 | GHDX | ↓ Sell | 3,000 | $33.36 | $100K | Direct | Nov 13, 2013 (5d) |
| Sep 6, 2013 | GHDX | ↓ Sell | 4,000 | $32.90 | $132K | Direct | Sep 10, 2013 (4d) |
| Aug 9, 2013 | GHDX | ↓ Sell | 4,000 | $33.15 | $133K | Direct | Aug 12, 2013 (3d) |
| Jul 9, 2013 | GHDX | ↓ Sell | 4,000 | $33.81 | $135K | Direct | Jul 10, 2013 (1d) |
| Jun 10, 2013 | GHDX | ↓ Sell | 4,000 | $35.88 | $144K | Direct | Jun 12, 2013 (2d) |
| May 9, 2013 | GHDX | ↓ Sell | 4,000 | $36.02 | $144K | Direct | May 13, 2013 (4d) |
| Jan 9, 2013 | GHDX | ↓ Sell | 2,625 | $28.00 | $74K | Direct | Jan 11, 2013 (2d) |
| Dec 11, 2012 | GHDX | ↓ Sell | 3,000 | $28.00 | $84K | Direct | Dec 12, 2012 (1d) |
| Nov 12, 2012 | GHDX | ↓ Sell | 3,000 | $28.00 | $84K | Direct | Nov 14, 2012 (2d) |
| Oct 12, 2012 | GHDX | ↓ Sell | 3,000 | $33.79 | $101K | Direct | Oct 16, 2012 (4d) |
| May 15, 2012 | GHDX | ↓ Sell | 1,000 | $33.69 | $34K | Direct | May 17, 2012 (2d) |
| Apr 16, 2012 | GHDX | ↓ Sell | 1,000 | $27.98 | $28K | Direct | Apr 17, 2012 (1d) |
| Mar 15, 2012 | GHDX | ↓ Sell | 1,000 | $31.08 | $31K | Direct | Mar 19, 2012 (4d) |
| Feb 15, 2012 | GHDX | ↓ Sell | 755 | $28.76 | $22K | Direct | Feb 17, 2012 (2d) |
| Jan 17, 2012 | GHDX | ↓ Sell | 1,000 | $28.00 | $28K | Direct | Jan 18, 2012 (1d) |
| Jun 15, 2011 | GHDX | ↓ Sell | 1,000 | $25.91 | $26K | Direct | Jun 16, 2011 (1d) |
| May 12, 2011 | GHDX | ↓ Sell | 1,000 | $26.48 | $26K | Direct | May 16, 2011 (4d) |
| Apr 14, 2011 | GHDX | ↓ Sell | 1,000 | $25.32 | $25K | Direct | Apr 18, 2011 (4d) |
| Mar 15, 2011 | GHDX | ↓ Sell | 1,000 | $23.79 | $24K | Direct | Mar 16, 2011 (1d) |
| Feb 15, 2011 | GHDX | ↓ Sell | 1,000 | $22.51 | $23K | Direct | Feb 16, 2011 (1d) |
| Jan 13, 2011 | GHDX | ↓ Sell | 1,276 | $21.06 | $27K | Direct | Jan 19, 2011 (6d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other RIGL insiders
Open-market trades in the last 12 months
About Dean L Schorno's insider trades
Dean L Schorno is EVP & Chief Financial Officer at Rigel Pharmaceuticals (RIGL). Since Jan 13, 2011, Dean has reported 1 open-market purchase worth $107K and 27 sales worth $1.8M on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (26 filings), option exercises (16 filings), shares withheld for taxes (7 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every RIGL insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.